Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Riata ICD Leads: Is there a problem or just a cosmetic issue?

Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.

Decongestive Strategies in Acute Heart Failure

Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.

Atrial Fibrillation: New Agents for Stroke Prevention

Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.

TCT/AHA Highlights: Platelets and Stem Cells

Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.

Update in Preventive Cardiology 2011

Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. HarrisCircadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald ReiterCardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. KebedPrevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema

AHA Abstract Presentations

Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.

Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.

Repairing Valves: Why and Why Not?

Dr. Alan J. Bank, Medical Director of Research at United Heart and Vascular Clinic, andAssociate Professor of Cardiology at the University of Minnesota, describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.

Cardiac Resynchronization Therapy: Developing a Center of Excellence

Dr. Nedaa Skeik, Vascular Medicine Consultant at the Minneapolis Heart Institute® atAbbott Northwestern Hospital, explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications (common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.

A Serious Complication of a Common Vascular Practice

Dr. Barry J. Maron, Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.

Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy

Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital, Dr. Robert Hauser, summarizes pacing hemodynamics, describes the value of cardiac synchronization, and explains ICD reliability and patient longevity.

Pacing the Heart: What side are you on?

As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and miscellaneous.

hubhopper

Minneapolis Heart Institute Foundation Cardiology Grand Roun...

hubhopper